These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19562325)

  • 1. In vitro amyloid Abeta(1-42) peptide aggregation monitoring by asymmetrical flow field-flow fractionation with multi-angle light scattering detection.
    Rambaldi DC; Zattoni A; Reschiglian P; Colombo R; De Lorenzi E
    Anal Bioanal Chem; 2009 Aug; 394(8):2145-9. PubMed ID: 19562325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate aggregation pathways of the Alzheimer beta-amyloid peptide: Abeta association kinetics at endosomal pH.
    Gorman PM; Yip CM; Fraser PE; Chakrabartty A
    J Mol Biol; 2003 Jan; 325(4):743-57. PubMed ID: 12507477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
    Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
    Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-Time Monitoring of Alzheimer's-Related Amyloid Aggregation via Probe Enhancement-Fluorescence Correlation Spectroscopy.
    Guan Y; Cao KJ; Cantlon A; Elbel K; Theodorakis EA; Walsh DM; Yang J; Shah JV
    ACS Chem Neurosci; 2015 Sep; 6(9):1503-8. PubMed ID: 26212450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Label-free detection of ApoE4-mediated β-amyloid aggregation on single nanoparticle uncovering Alzheimer's disease.
    Kang MK; Lee J; Nguyen AH; Sim SJ
    Biosens Bioelectron; 2015 Oct; 72():197-204. PubMed ID: 25982728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct electrochemical and AFM detection of amyloid-β peptide aggregation on basal plane HOPG.
    Lopes P; Xu M; Zhang M; Zhou T; Yang Y; Wang C; Ferapontova EE
    Nanoscale; 2014 Jul; 6(14):7853-7. PubMed ID: 24934601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermal aggregation of bovine serum albumin studied by asymmetrical flow field-flow fractionation.
    Yohannes G; Wiedmer SK; Elomaa M; Jussila M; Aseyev V; Riekkola ML
    Anal Chim Acta; 2010 Aug; 675(2):191-8. PubMed ID: 20800732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
    Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
    Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration dependent Cu2+ induced aggregation and dityrosine formation of the Alzheimer's disease amyloid-beta peptide.
    Smith DP; Ciccotosto GD; Tew DJ; Fodero-Tavoletti MT; Johanssen T; Masters CL; Barnham KJ; Cappai R
    Biochemistry; 2007 Mar; 46(10):2881-91. PubMed ID: 17297919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
    Poduslo JF; Howell KG
    J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large size fibrillar bundles of the Alzheimer amyloid beta-protein.
    Carrotta R; Barthès J; Longo A; Martorana V; Manno M; Portale G; San Biagio PL
    Eur Biophys J; 2007 Sep; 36(7):701-9. PubMed ID: 17492436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering of a peptide probe for β-amyloid aggregates.
    Aoraha E; Candreva J; Kim JR
    Mol Biosyst; 2015 Aug; 11(8):2281-9. PubMed ID: 26073444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of early stage intermediates in the nucleation phase of Aβ aggregation.
    Zhai J; Lee TH; Small DH; Aguilar MI
    Biochemistry; 2012 Feb; 51(6):1070-8. PubMed ID: 22283417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asymmetrical flow field-flow fractionation with multi-angle light scattering and quasi elastic light scattering for characterization of poly(ethyleneglycol-b-ɛ-caprolactone) block copolymer self-assemblies used as drug carriers for photodynamic therapy.
    Ehrhart J; Mingotaud AF; Violleau F
    J Chromatogr A; 2011 Jul; 1218(27):4249-56. PubMed ID: 21300359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation.
    Abelein A; Gräslund A; Danielsson J
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5407-12. PubMed ID: 25825723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymmetrical flow field-flow fractionation with multi-angle light scattering detection for the analysis of structured nanoparticles.
    Zattoni A; Rambaldi DC; Reschiglian P; Melucci M; Krol S; Garcia AM; Sanz-Medel A; Roessner D; Johann C
    J Chromatogr A; 2009 Dec; 1216(52):9106-12. PubMed ID: 19576590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biophysical comparison of soluble amyloid-β(1-42) protofibrils, oligomers, and protofilaments.
    Nichols MR; Colvin BA; Hood EA; Paranjape GS; Osborn DC; Terrill-Usery SE
    Biochemistry; 2015 Apr; 54(13):2193-204. PubMed ID: 25756466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
    Rijal Upadhaya A; Kosterin I; Kumar S; von Arnim CA; Yamaguchi H; Fändrich M; Walter J; Thal DR
    Brain; 2014 Mar; 137(Pt 3):887-903. PubMed ID: 24519982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.